Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City
Time:July 24,2023
Source:Shanghai ConFlow MedTech Co., Ltd., 
Share:

The Shanghai Municipal Commission of Economy and Information Technology has officially unveiled its "2023 Roster of Specialized and Sophisticated Small and Medium-Sized Enterprises (SMEs) in Shanghai (First Batch)." Following rigorous expert evaluations and comprehensive assessments, ConFlow MedTech has emerged as a standout among numerous participating enterprises, earning the prestigious title of "Specialized and Sophisticated" SEM in Shanghai City.

 

 

Specialized, refined, distinctive and innovative

 

These Specialized and Sophisticated enterprises epitomize SMEs with unique characteristics including: Professional, Proficient, Special and New.

Professional:Professionally specialize and excel in targeted facets or products within the industrial chain, emphasizing expertise in specialized technologies.

Proficient: Excel in refined production, management, and services.

Special:    Offer well-targeted products or services with characteristics that distinguish a business from the industry competitors.   

New: Prioritize independent and model innovation

"Specialized and Sophisticated" SEMs are characterized by their high technological content, high-end equipment and processes, comprehensive management systems, and robust market competitiveness. They serve as catalysts for regional economic innovation and development, aligning closely with the national innovation-driven development strategy. The award bestowed upon ConFlow MedTech as a "Specialized and Sophisticated" SME signifies a significant acknowledgment of the innovative medical devices developed by the company. It also serves as a certification of the company's research prowess, innovation capacity, and comprehensive strength.

Looking ahead, ConFlow MedTech is unremittingly committed to pursuing the path of specialization, refinement, distinctiveness, and innovation. The company will continue its dedicated efforts in the field of structural heart disease, guided by scientific research and innovation. The company, driven by innovation, is deeply rooted in addressing clinical and patient needs. Through ongoing independent R&D and the clinical transformation of cutting-edge high-tech solutions, ConFlow MedTech will drive high-quality development and deliver internationally leading product technology and services to a wider range of structural heart disease patients.

Pride in progress,
Pursue further excellence!